P06756 (ITAV_HUMAN) Homo sapiens (Human)

Integrin alpha-V UniProtKBInterProSTRINGInteractive Modelling

1048 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3); 1 identical sequence: Homo sapiens: L7RXH0

Available Structures

36 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Crystal structure of the complete integrin alhaVbeta3 ectodomain plus an Alpha/beta transmembrane f…
3ije
 Heteromer
P05106; 		31-997
1×NAG; 6×NAG; 1×NAG; 2×NAG; 5×NAG; 6×CA;
Assess
Re-refinement of alpha V beta 3 structure
4g1m
 Heteromer
P05106; 		31-989
1×NAG; 9×NAG; 1×NAG; 1×NAG; 7×CA; 4×NAG; 1×NA;
Assess
Crystal structure of integrin alpha V beta 3 with coil-coiled tag.
4g1e
 Heteromer
P05106; 		31-989
4×NAG; 3×NAG; 1×NAG; 4×NAG; 1×NAG; 6×CA; 2×NAG; 6×SO4; 7×CL; 1×NI;
Assess
CRYSTAL STRUCTURE OF THE EXTRACELLULAR SEGMENT OF INTEGRIN ALPHAVBETA3
1jv2
 Heteromer
P05106; 		31-986
4×NAG; 3×NAG; 4×NAG; 6×CA;
Assess
A novel adaptation of the integrin PSI domain revealed from its crystal structure
1u8c
 Heteromer
P05106; 		31-986
4×NAG; 3×NAG; 5×NAG; 6×CA;
Assess
Integrin AlphaVBeta3 ectodomain bound to EETI-II 2.5D
6msl
 Heteromer
P05106; P12071; 		31-986
2×NAG; 5×NAG; 1×NAG; 1×NAG; 4×NAG; 8×MN;
Assess
Integrin alphaVBeta3 in complex with EETI-II 2.5F
6msu
 Heteromer
P05106; P12071; 		31-986
2×NAG; 4×NAG; 1×NAG; 2×NAG; 5×NAG; 8×MN; 1×CL;
Assess
Integrin AlphaVBeta3 ectodomain bound to the tenth domain of Fibronectin with the IAKGDWND motif
4mmy
 Heteromer
P02751; P05106; 		31-986
2×NAG; 4×NAG; 1×NAG; 2×NAG; 5×NAG; 8×MN;
Assess
CRYSTAL STRUCTURE OF THE EXTRACELLULAR SEGMENT OF INTEGRIN AVB3 IN COMPLEX WITH AN ARG-GLY-ASP LIGA…
1l5g
 Heteromer
P05106; 		31-986
4×NAG; 3×NAG; 4×NAG; 8×MN;
Assess
CRYSTAL STRUCTURE OF THE EXTRACELLULAR SEGMENT OF INTEGRIN ALPHA VBETA3 BOUND TO MN2+
1m1x
 Heteromer
P05106; 		31-986
4×NAG; 3×NAG; 4×NAG; 6×MN;
Assess
Integrin AlphaVBeta3 ectodomain bound to the tenth domain of Fibronectin
4mmx
 Heteromer
P02751; P05106; 		31-986
2×NAG; 4×NAG; 1×NAG; 2×NAG; 5×NAG; 8×MN;
Assess
The Therapeutic Antibody LM609 Selectively Inhibits Ligand Binding to Human alpha-V beta-3 Integrin…
6avq
 Heteromer
P05106; 		31-986
Assess
Integrin AlphaVBeta3 ectodomain bound to antagonist TDI-4161
6mk0
 Heteromer
P05106; 		31-984
4×NAG; 1×NAG; 1×NAG; 8×NAG; 8×MN; 1×JUY;
Assess
Integrin AlphaVBeta3 ectodomain bound to Hr10 variant of the 10th domain of Fibronectin.
6naj
 Heteromer
P02751; P05106; 		31-984
5×NAG; 1×NAG; 1×NAG; 7×NAG; 8×MN;
Assess
Integrin AlphaVBeta3 ectodomain bound to an antagonistic tenth domain of Fibronectin
4mmz
 Heteromer
P02751; P05106; 		31-984
4×NAG; 1×NAG; 1×NAG; 8×NAG; 8×MN; 1×NA; 2×GOL;
Assess
AlphaVBeta3 integrin in complex with monoclonal antibody FAB fragment.
4o02
 Heteromer
P05106; 		31-983
1×NAG; 1×NAG; 2×NAG; 3×NAG; 3×NAG; 5×MN; 2×NO3;
Assess
Human alpha-V beta-3 Integrin (intermediate conformation) in complex with the therapeutic antibody …
6avr
 Heteromer
P05106; 		31-983
Assess
Human alpha-V beta-3 Integrin (open conformation) in complex with the therapeutic antibody LM609
6avu
 Heteromer
P05106; 		31-982
Assess
Integrin alpha V beta 6 in complex with pro-TGF-beta
5ffo
 Heteromer
P01137; P18564; 		31-625
2×NAG; 3×NAG; 2×NAG; 5×NAG; 2×NAG; 8×CA; 4×NAG; 6×MN;
Assess
Crystal structure of alpha V beta 6 with peptide
4um9
 Heteromer
P10600; P18564; 		31-624
2×NAG; 1×NAG; 1×NAG; 2×SO4; 6×CA; 5×NAG; 1×MAN; 1×MG;
Assess
Crystal structure of an atypical integrin
6om1
 Heteromer
P26012; 		31-624
3×NAG; 1×NAG; 1×NAG; 2×NAG; 2×NAG; 5×CA; 3×EDO; 1×MG; 1×MES;
Assess
Crystal structure of atypical integrin alphaV beta8 with proTGF-beta1 ligand peptide
6om2
 Heteromer
P01137; P26012; 		31-624
3×NAG; 3×NAG; 1×NAG; 1×NAG; 4×NAG; 1×NAG; 10×CA; 3×NAG; 2×PEG; 2×MG; 1×GLY;
Assess
Crystal structure of alpha V beta 6
4um8
 Heteromer
P18564; 		31-624
1×NAG; 2×NAG; 1×NAG; 1×NAG; 1×NAG; 1×CL; 3×SO4; 1×NI; 5×CA; 1×CAC; 1×MG; 1×NAG;
Assess
Localised Reconstruction of Integrin alpha V beta 6 bound to Foot and Mouth Disease Virus O1 Manisa…
5neu
 Heteromer
D1H101; P18564; Q6PMW3; 		31-624
1×MG; 2×CA;
Assess
Localised Reconstruction of Integrin alpha V beta 6 bound to Foot and Mouth Disease Virus O1 Manisa…
5net
 Heteromer
D1H101; P18564; Q6PMW3; 		31-624
2×NAG; 1×MAN; 2×NAG; 3×MAN; 3×NAG; 4×CA;
Assess
Localised reconstruction of alpha v beta 6 bound to Foot and Mouth Disease Virus O PanAsia - Pose A.
5nem
 Heteromer
A6Y878; P18564; Q6ZZ87; Q98W00; 		31-624
2×NAG; 1×MAN; 2×NAG; 3×MAN; 3×NAG; 4×CA;
Assess
Localised reconstruction of alpha v beta 6 bound to Foot and Mouth Disease Virus O PanAsia - Pose A…
5ner
 Heteromer
A6Y878; P18564; Q6ZZ87; Q98W00; 		31-624
1×MAN; 1×NAG; 1×NAG; 2×NAG; 3×MAN; 4×NAG; 4×CA;
Assess
Crystal structure of integrin alpha V beta 6 head
5ffg
 Heteromer
P18564; 		31-623
1×NAG; 2×NAG; 1×NAG; 1×NAG; 6×CA; 2×NAG; 1×SO4; 1×MES; 2×PEG;
Assess
Integrin alpha-v beta-8 in complex with pro-TGF-beta1
6uja
 Heteromer
P07200; P26012; 		31-623
1×NAG; 4×NAG; 5×CA; 3×NAG; 1×MG;
Assess
Integrin alpha-v beta-8 in complex with the Fabs 8B8 and 68
6djp
 Heteromer
P26012; 		31-623
6×NAG; 1×NAG; 1×NAG; 2×NAG;
Assess
Integrin alpha-v beta-8 in complex with the Fabs C6D4 and 11D12v2
6ujb
 Heteromer
P26012; 		31-623
1×NAG; 4×NAG; 5×CA; 3×NAG; 1×MG;
Assess
Integrin alpha-v beta-8 in complex with the Fabs C6-RGD3 and 11D12v2
6ujc
 Heteromer
P26012; 		31-623
1×NAG; 4×NAG; 5×CA; 3×NAG; 1×MG;
Assess
Complex of integrin alphaV/beta8 and L-TGF-beta1 at a ratio of 1:2
7y1t
 Heteromer
P01137; P26012; 		31-617
1×NAG; 2×NAG; 1×NAG; 5×NAG; 5×CA; 1×MN;
Assess
Cryo-EM structure of Integrin AVB3
8ij5
 Heteromer
P05106; 		31-616
Assess
Integrin alpha-v beta-8 in complex with minibinder B8_BP_dsulf
8tcf
 Heteromer
P26012; 		31-473
1×NAG; 3×NAG; 5×CA; 4×NAG; 1×MG;
Assess
Integrin alpha-v beta-6 in complex with minibinder B6_BP_dslf
8tcg
 Heteromer
P18564; 		31-469
1×NAG; 4×CA; 2×NAG; 3×MN;
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
3ije.1.Amonomer0.8131-997
1×NAG; 5×CA;100.00
Assess

2 SWISS-MODEL models built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 23ije.1.Amonomer0.7731-961
1×NAG; 5×CA;99.89
Assess
Isoform 33ije.1.Amonomer0.808-951
1×NAG; 5×CA;99.05
Assess